Cargando…
DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism
BACKGROUND: The stability of p53 is mainly controlled by ubiquitin-dependent degradation, which is triggered by the E3 ubiquitin ligase MDM2. The chromatin modifier lymphoid-specific helicase (LSH) is essential for DNA methylation and cancer progression as a transcriptional repressor. The potential...
Autores principales: | Chen, Ling, Shi, Ying, Liu, Na, Wang, Zuli, Yang, Rui, Yan, Bin, Liu, Xiaoli, Lai, Weiwei, Liu, Yating, Xiao, Desheng, Zhou, Hu, Cheng, Yan, Cao, Ya, Liu, Shuang, Xia, Zanxian, Tao, Yongguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781351/ https://www.ncbi.nlm.nih.gov/pubmed/31594538 http://dx.doi.org/10.1186/s13072-019-0302-9 |
Ejemplares similares
-
The ubiquitin‐specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression
por: Yan, Bokang, et al.
Publicado: (2023) -
GINS4 suppresses ferroptosis by antagonizing p53 acetylation with Snail
por: Chen, Ling, et al.
Publicado: (2023) -
LSH interacts with and stabilizes GINS4 transcript that promotes tumourigenesis in non-small cell lung cancer
por: Yang, Rui, et al.
Publicado: (2019) -
The Significance of HOXC11 and LSH in Survival Prediction in Gastric Adenocarcinoma
por: Peng, Xin, et al.
Publicado: (2021) -
Regression based predictor for p53 transactivation
por: Gowrisankar, Sivakumar, et al.
Publicado: (2009)